Opinion statement Chemotherapy-induced peripheral neuropathy (CIPN) is a common
toxicity associated with multiple chemotherapeutic agents. CIPN may have a detrimental …

CIPN is a common, potentially severe and dose-limiting adverse effect of cancer treatment.
Chemotherapies mainly target axons, dorsal root ganglia and terminal trees of …

Objective This study aims to investigate the presence of bilateral pressure pain
hypersensitivity in arm trunk nerves and upper limb mechanosensitivity in breast cancer …

Cancer treatment-related chronic neuropathic pain (NP) is a pervasive and distressing
problem that negatively influences function and quality of life for countless cancer survivors …

Medical oncology has come a long way since early chemotherapy studies for advanced-
stage cancers. For most malignancies, we now have multiple treatment options to discuss …

Microtubules have been among the most successful targets in anticancer therapy and a
large number of microtubule-targeting agents (MTAs) are in various stages of clinical …

There are few of us practicing oncology today who remember what cancer care was like in
the 1960s, when the American Society of Clinical Oncology (ASCO) was founded. From my …

Damage to motor, sensory, or autonomic nerves secondary to antineoplastic chemotherapy
can result in varying degrees of dysfunction and/or pain, which can lead to significant …

Microtubule targeting agents (MTAs) are chemotherapeutics commonly used in the
treatment of breast, ovarian, lung, and lymphoma cancers. There are two main classes of …